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Abstract
Rationale and Objectives—Test sets for assessing and improving radiologic image
interpretation have been used for decades and typically evaluate performance relative to gold-
standard interpretations by experts. To assess test sets for screening mammography, a gold-
standard for whether a woman should be recalled for additional work-up is needed, given that
interval cancers may be occult on mammography and some findings ultimately determined to be
benign require additional imaging to determine if biopsy is warranted. Using experts to set a gold-
standard assumes little variation occurs in their interpretations, but this has not been explicitly
studied in mammography.
Materials and Methods—Using digitized films from 314 screening mammography exams
(n=143 cancer cases) performed in the Breast Cancer Surveillance Consortium, we evaluated
interpretive agreement among three expert radiologists who independently assessed whether each
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examination should be recalled, and the lesion location, finding type (mass, calcification,
asymmetric density, or architectural distortion), and interpretive difficulty in the recalled images.
Results—Agreement among the three expert pairs for recall/no recall was higher for cancer cases
(mean 74.3 ± 6.5) than for non-cancers (mean 62.6 ± 7.1). Complete agreement on recall, lesion
location, finding type and difficulty ranged from 36.4%–42.0% for cancer cases and from 43.9%–
65.6% for non-cancer cases. Two of three experts agreed on recall and lesion location for 95.1%
of cancer cases and 91.8% of non-cancer cases, but all three experts agreed on only 55.2% of
cancer cases and 42.1% of non-cancer cases.
Conclusion—Variability in expert interpretive is notable. A minimum of three independent
experts combined with a consensus should be used for establishing any gold-standard
interpretation for test sets, especially for non-cancer cases.
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INTRODUCTION
In radiology, test sets have been used for decades to assess and improve interpretive
performance (1,2). Typically, the gold-standard for interpretation is either based on observed
patient outcomes, or is based on expert review where a panel of experts comes to consensus
on the interpretation. In the latter, the consensus decision becomes the gold-standard and
provides the basis for measuring individual performance. Little is known about the extent to
which expert radiologists vary in interpretive assessments. Importantly, agreement among
mammography experts has not been examined in the context of test set development in
screening mammography, though test sets are frequently used for educational purposes.
The high prevalence of screening mammography use in the population and wide variability
in radiologists’ interpretive performance of mammography (3,4) makes the issue of testing
radiologists for interpretation ability clinically important. Test sets are also useful for
evaluating interventions aimed at improving interpretation, because it is difficult to assess
changes in screening mammography performance in clinical practice due to low within-
practice breast cancer prevalence and the long lag-time for obtaining true cancer status. For
screening mammography test sets, breast cancer status may be considered the ultimate gold-
standard, but it also unrealistically applies a diagnostic standard of performance to a
screening test. In contrast, a gold standard for whether or not the exam should be recalled for
additional work-up and the location and type of any significant findings would be more
clinically relevant, because it measures performance based on the fact that some interval
cancers are occult on prior mammography and some findings ultimately determined to be
benign required additional imaging to determine if biopsy is warranted. The nature of
screening makes having clear objective criteria for a recall decision to evaluate a suspicious
finding or identification of significant findings difficult, but using biopsy results within one
year of screening as the gold standard unrealistically judges all false negatives and false
positives as avoidable errors.
Using experts to set the gold-standard for recall presumes there is little variation in their
interpretive threshold. However, little empirical evidence exists upon which to base this
assumption for screening mammography, since most studies where gold-standards have
been established were not limited to experts. Experts may often use different nomenclature
to describe essentially the same mammographic finding. However, nomenclature variability
used by expert radiologists interpreting the same set of mammograms has not been studied.
Many studies have examined radiologist agreement of mammographic interpretation, but
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these did not specifically focus on expert agreement, which we would expect to be higher
compared with non-expert radiologists, or gold standard development for test sets (5–10).
An older study in chest radiography assessed methods for determining “truth” and found that
no single method based on radiologists’ interpretation was adequate (11). Agreement among
experts should be examined to inform the development of standards for the number of
experts to include when setting a gold standard interpretation to assess test set data.
Our objective was to develop a gold standard interpretation for mammography using an
expert panel for a project that included developing tests sets to evaluate the interpretive
accuracy of community radiologists. We specifically assessed interpretive agreement among
three expert radiologists who independently reviewed the same digitized film screening
mammograms to set the gold-standard. We examined agreement for recall, lesion location,
finding type, and case difficulty. We compared the degree to which requiring agreement for
two of three, versus three of three, experts affected setting the gold-standard. Given that test
sets are used to measure interpretive accuracy based on a gold standard interpretation, an
empirical look at levels of agreement among experts in developing the gold standard is
informative to accuracy assessment.
MATERIALS AND METHODS
Protection of Study Subjects
The screening mammography films, digitized for this study, came from five mammography
registries located in San Francisco, California; western Washington; North Carolina;
Vermont; and New Hampshire, which are associated with the National Cancer Institute-
funded Breast Cancer Surveillance Consortium (BCSC) (12,13). Each registry and the
Statistical Coordinating Center (SCC), where the analysis was performed, received
institutional review board (IRB) approval for either active or passive consenting processes
or a waiver of consent to enroll participants, link data, and perform analytic studies. The
expert radiologists consented to participate in the study. All registries follow procedures that
are Health Insurance Portability and Accountability Act (HIPAA) compliant, and all
registries and the SCC have received a Federal Certificate of Confidentiality (14) and other
protection for the identities of women, physicians, and facilities related to the images used in
this research.
Mammograms Reviewed by Experts
The test set development is described in detail elsewhere (15). Briefly, the test sets were
developed for the Assessing and Improving Mammography (AIM) study in which we
randomly selected films from women aged 40–69 years who received screening between
2000 and 2003. All exams were required to have comparison films from the prior 11–30
months. Films were excluded if the woman had a history of breast cancer or breast
augmentation. Cancer cases included diagnoses of ductal carcinoma in situ (DCIS) or
invasive breast cancer within 12 months from the date of the screening exam and all non-
cancer cases remained cancer free for 24 months following the screening exam. A total of
314 cases (each having eight images: four current and four prior) were digitized by
specialists at the American College of Radiology and placed on a DVD with software
designed to record the review decisions of the expert radiologists.
Expert Review Process
Three expert radiologists participated in this study, all are senior radiologists in academic
medical centers who teach and specialize in breast imaging. Each radiologist independently
reviewed the DVD of 314 cases on either their personal or work computer, using computer
specifications that were the same as those for radiologists participating in the test set study: a
Onega et al. Page 3













large screen size, high-resolution graphics (1280×1024, 3 GHz, 1 GB of RAM, and a video
card with 128 MB of memory capable of displaying full 32-bit color at the listed
resolutions), and a DVD reader. The software let the radiologists view the craniocaudal and
mediolateral oblique films in their preferred placement of left and right breasts and allowed
image enlargement and comparison images. Experts were blinded to the original clinical
mammography interpretations and cancer status of all mammograms.
The radiologists evaluated each mammogram for recall (yes or no), as defined by the
American College of Radiology BI-RADS® atlas: recall = assessment codes 0, 4 and 5; and
no recall = codes 1 and 2 (16). When they chose recall, they also gave the laterality,
location, and finding type (mass, calcification, architectural distortion, or asymmetry) of the
most important finding and the level of difficulty of identifying the finding (obvious,
intermediate, subtle). The experts specified location of the most important finding in two
ways: 1) They clicked on the lesion in the computer image of the film, the coordinates of
which were stored by the computer software; and 2) they identified the quadrant where the
lesion was located (upper outer, upper inner, lower outer, lower inner, or unable to
determine).
After the independent expert reviews were complete, their interpretations were evaluated for
agreement. Complete agreement among the initial reviews was defined as cases for which at
least two of the three experts agreed on each of the indicators (recall, location, finding type,
and difficulty). The experts came together for an in-person consensus meeting to discuss
cases (n=68) with no initial agreement. The experts discussed these cases until they achieved
consensus. The “gold-standard” interpretation for the test set was established using the
majority opinion for cases with agreement of the initial review and the consensus
interpretation for cases evaluated at the in-person consensus meeting. We used this approach
to establish the gold standard because two readers have been shown to be superior to one in
clinical practice, with either consensus by a third reader to resolve discordant interpretations
or having positive interpretations overrule negative interpretations in discordant pairs.
(16,17) The evidence suggests little additional value of having more than 3 readers.(18)
Analysis
Data from the experts’ independent and consensus reviews were sent to the SCC for
analysis, which included description of agreement among the three experts on recall, and on
location, finding type, and difficulty for the recalled cases. For cases in which a significant
finding was noted and recall was recommended, lesion location was assessed for agreement
by comparing click locations on the mammogram to determine whether the same lesion was
indicated. Two reviewers independently evaluated agreement of the click locations as: 1)
clearly indicating the same lesion (Figure 1); 2) clearly indicating different lesions (for
example, clicks with different laterality) (Figure 2); or 3) agreement uncertain, further
review needed (Figure 3). All films where concordance was uncertain or the experts clicked
different film views (one expert clicked the CC and the other clicked the MLO) (Figure 3),
were reviewed by an independent expert radiologist affiliated with the study team but who
did not participate in the development of the test set. Review for lesion location agreement
was necessary for 34 (22.8%) of the 149 films for which at least two experts indicated recall.
We used descriptive statistics to summarize the age, current hormone therapy use,
menopausal status, and breast density of the women whose mammograms this study
included. For cases where cancer was detected in the follow-up year, we described cancer
characteristics including tumor type (invasive or in situ), size, nodal status, grade, and
estrogen receptor (ER) and progesterone receptor (PR) status.
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To describe variability of assessments between experts, we defined five successive levels of
agreement: 1) woman-level agreement required experts to agree only on whether or not the
woman should be recalled; 2) breast-level agreement additionally required selection of the
same laterality; 3) lesion-level agreement further required that experts clicked on the same
lesion; 4) finding-level agreement required that experts identified the same lesion and agreed
on finding type; and 5) complete agreement required finding-level agreement, with
additional agreement on the difficulty rating (Table 1).
To characterize pair-wise variability in expert mammography assessment, we reviewed
agreement for each possible unique pair of radiologists, summarizing the proportion of
mammograms where the experts agree for each of the different levels of agreement,
stratified by cancer status.
We compared two methods for defining the gold-standard: 1) require all three experts to
agree; or 2) use majority opinion, requiring only that any two experts agree. To describe the
agreement among all three experts, we report two sets of results based on these two
strategies for defining the gold-standard. For each of the five levels of agreement defined
above, we report the proportion of mammograms for which all three experts agree, and the
proportion for which any two agree (Table 1). Differences in findings nomenclature were
summarized by the experts’ finding types where there was lesion-level agreement.
The set of cases for review included 46% (N=143) with cancer and 54% (N=171) without
cancer. All analyses were done using Stata/SE version 10.1 (Stata Corp. LP, College Station,
Texas).
RESULTS
Of the 314 exams, 33% of films were from women ages 40–49, 41% from women ages 50–
59, and 25% from women ages 60–69 years; 46% were on hormones at the time of the
mammogram, and 77% were postmenopausal (Table 2). Of the 143 cancers diagnosed
within a year of the screening mammogram, 81% (N=116) were invasive and 19% (N=27)
DCIS. Of the 116 invasive cancers, 34% (N=37) were ≤1 cm in size, and 23% (N=72) were
>2 cm; size was missing for 6% (N=7). Lymph node status was positive in 29% (N=32),
grade 1 or 2 in 67% (N=66), and ER/PR status was positive/positive in 71.4% (N=60) and
negative/negative in 16% (N=13) (Table 3).
Recall rates varied among the expert radiologists: 34.4% for expert 1, 51.3% for expert 2,
and 65.7% for expert 3. Among the 314 exams reviewed, 24.5% (N=77) were recalled by
none of the three experts, 28.0% (N=88) by one expert, 20.1% (N=63) by two experts, and
27.4% (N=86) by all three experts.
Table 4 summarizes pair-wise agreement in the expert reviews, showing the variability in
agreement observed among pairs of experts. Agreement not to recall without cancer among
the three unique pairings of the radiologists was 40.9%, 49.1%, and 63.7%. Pair-wise
agreement to recall with cancer was 53.9%, 57.3%, and 72.7%. Overall agreement (agree to
recall, or agree not to recall) at the woman level was 57.9%, 59.1%, and 70.8% for films
without cancer, and 69.9%, 71.3%, and 81.8% for films with cancer. For all pairs, overall
breast-level and lesion-level agreement was slightly lower than woman-level agreement.
Overall complete agreement, which required lesion-level agreement plus agreement on
finding type and difficulty rating, was 36.4%, 37.1%, and 42.0% for cancers and 43.9%,
53.8%, 65.6% for non-cancers. The higher level of complete agreement among non-cancer
cases was due to lower recall rate among these mammograms.
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Table 5 outlines agreement for the two gold-standard setting scenarios we tested (all three
experts agreed, or any two of the three experts agreed). All three experts agreed to recall 75
of 143 (52.4%) cancer cases. All three also agreed on no-recall for 13 (9.1%) of the cancer
cases, resulting in an overall woman-level agreement of 88/143 (61.5%) of cancers. Unlike
pair-wise agreement, agreement tends to be greater for cancer cases than non-cancer cases
when all three experts are required to agree.
Agreement among three experts was considerably higher if requiring only two of the three
radiologists, rather than all three, to agree. Among cancer cases, agreement was 79.0% for
two of three independent expert readings and 52.4% for three of three; for non-cancer cases,
agreement was 21.1% for two of three experts and 6.4% for all three.
When the standard for agreement was based on at least two of three expert readings, lesion-
level agreement occurred in 91.8% of non-cancer cases and 95.1% of cancer cases; and
complete agreement in 86.0% of non-cancer and 73.4% of cancer cases (Table 5). This
contrasted with agreement based on three of three expert reviews, in which lesion-level
agreement was 42.1% for non-cancers and 55.2% for cancers, and complete agreement was
38.6% for non-cancers and 21.0% for cancer cases.
We examined the proportion of cases for which the three of three expert consensus decision
agreed with the decision when only two of three agreed prior to going to consensus review.
For cancer cases, the consensus (three-of-three) decision agreed with the two of three
radiologists’ decision in 93% of the cancer cases and 53% of the non-cancer cases at the
breast level. When cancer is present (based on objective pathology), there is less variability
among experts as to whether or not to recall, and thus fewer experts may suffice for setting
the recall standard for cancer cases.
Table 6 shows the variability of finding types with lesion-level agreement. The distribution
of finding types for cases where experts agreed on type is shown separately for lesions that
were recalled by two experts and those that were recalled by three experts. Similarly, when
experts disagreed on finding type, the combinations of finding types are shown by the
number of experts who recalled the lesion. In 54 cases, two experts recalled the same lesion
and the other expert did not; and in 74 cases, all three experts recalled the same lesion.
When all three experts agreed on the lesion, they agreed on finding type for 51/74 (69%) of
the identified lesions; when two of three radiologists agreed on the lesion, they agreed on the
type for 38/54 (70%). For lesions recalled by all three experts who disagreed on the finding
type, the disagreement was mass versus asymmetry 70% (16/23) of the time. When two
radiologists recalled the lesion and disagreed on finding, the disagreement was most
frequently related to characterizing the findings as a mass versus asymmetry 38% (6/16) and
calcification versus architectural distortion 25% (4/16).
DISCUSSION
We assessed variability in interpretive agreement among three expert breast imagers to
define a gold-standard for test sets to be used in a study of screening mammography
performance. Our results showed the expected increased variability in agreement among the
experts when stricter levels of agreement were required to set the gold-standard. Our results
also showed that requiring two of three, rather than complete consensus when setting a gold-
standard for test sets results in a notable decrease in the number of cases needing review and
discussion. Complete agreement, which required lesion-level agreement and agreement on
finding type and difficulty rating, was notably higher for non-cancer cases than cancer cases.
Mass versus asymmetry was the leading difference in describing finding type when
interpretation varied. Our results demonstrate that interpretive variation exists, even among
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experts, and test set development benefits from the development of a priori rules to guide
setting a gold-standard, such as nomenclature for benign findings. Our results suggest that at
least three experts are needed for developing a gold-standard mammography interpretation,
especially for non-cancer cases; however, the optimal number of experts and the proportion
of agreement needed in gold-standard development are still questions requiring further
research.
Variation among experts to develop a gold-standard has not been examined previously, but
is important to quantify for several reasons: 1) Gold-standard interpretations have a degree
of uncertainty, which is not accounted for in measuring accuracy of test-takers; 2) cancer
cases can be considered to have objective ‘truth’, when the lesion is visible on the images,
but non-cancer cases do not; and 3) optimal approaches to developing gold-standard
interpretations should be identified to help standardize test set development so results are
comparable across studies and establish achievable and practical quality standards for
clinical practice. Careful review of the literature shows little attention to variation among
experts in developing gold-standards, particularly for mammography. Several studies have
examined expert interpretation variability in clinical practice. A British study examined
agreement among three experienced radiologists for interpreting emergency radiographs
(19). They found 51% to 74% concordance of expert pairs and concluded that this inter-
observer variation should be accounted for in setting quality standards and designing
assessment tools (19). Similarly, a study of six thyroid pathology experts found considerable
inter-observer variability, with unanimous agreement in 13% of cases and majority
agreement in 40% (20). This scant literature suggests that expert interpretive variation is
higher than might be expected and should be recognized as a potential source of variability
in performance studies (21,22).
Although pathology-confirmed breast cancer status is the ultimate gold-standard for
mammography, having perfect mammography performance relative to true cancer status is
impossible given limitations in the technology, and also undesirable in performance studies.
Radiologists should not be penalized on a test set for not recalling a cancer case that is
unable to be detected by mammography. Likewise, experts may agree that some findings on
screening views should be recalled for further evaluation to determine if they should be
biopsied – even if it is later determined that these findings are benign. That is, a proportion
of non-cancer cases are “appropriate recalls”, yet determining this requires a subjective
assessment best developed by expert panels. Thus, for screening mammography test sets, we
believe it is important to have a gold-standard interpretation for whether the exams should
be recalled for additional work-up, based on expert opinion, given that in typical clinical
practice some exams that ultimately are determined to not be cancer, still require workup.
Our results suggest that at least three experts should be used to develop this type of gold-
standard.
Our study, and that of Elsheikh et al., (20) demonstrate that requiring agreement of more
experts decreases the proportion of cases in which agreement is found. A tradeoff exists:
including more experts and therefore potentially better approximating “truth” yet reducing
agreement, versus maximizing agreement, but including more “noise” by having fewer
expert opinions. This tradeoff can be approached with various strategies. For example, test
sets for the ACR’s Mammography Case Review are developed by onsite consensus among
six to nine experts (23).
Our study had several limitations. First, the expert radiologists were reviewing digitized
images of film studies and were viewing them on personal computers. The resulting
digitized images were not of diagnostic quality, and this may have increased variability
among the experts. However, each was viewing the same set of digitized images; so image
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quality would affect the expert radiologists equally and parallel the conditions study
radiologists viewed when taking the test set. Finally, although poor quality images were
excluded in our study, our study images were not selected based on whether the findings
were readily visible, as is the case for CME cases designed for review on a personal
computer, such as in the ACR Mammography Case Review product (23). Instead, our goal
was to select a clinically representative sample of films with and without cancer, as was
consistent with the overarching goals of the test set study design.
Key questions arise from our study, such as whether we should expect non-expert
radiologists interpreting images in a test set to be measured against a gold-standard set by
experts given even experts often do not agree. Lack of perfect concordance in judgment has
been documented in most medical specialties, and thus it is reasonable to benchmark the
level of agreement between experts, even if imperfect. We feel that gold-standard
interpretation for mammography test sets should not be based on cancer status alone, since
some cancers may not be visible on mammography and some findings that turn out to be
benign did require work-up and recalling the patient was the clinically correct decision.
Consensus meetings of at least three experts seem to be a good method to approximate the
“truth,” given interpretive variability even among experts. However, the test takers are
evaluated based on their individual interpretation compared to a consensus interpretation.
Regardless of the approach used to develop a gold-standard, interpretation in clinical
settings for which objective truth is more difficult raises an important issue regarding how
best to evaluate non-expert physicians against a standard that may vary substantively even
among experts. The results of this study demonstrate the need to rigorously address this
methodological issue in mammography and other clinical arenas.
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Expert agreement: three experts recalled, same lesion, as indicated by the three click (▲)
locations.
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No expert agreement: two experts recalled, different lesions as shown by click (▲) locations
in different breasts.
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Expert agreement in need of review: 3 experts recall, two agree, but unclear whether 3rd
expert has indicated the same lesion, as indicated by the three click (▲) locations.
Onega et al. Page 13

























Onega et al. Page 14
Table 1
Measurement of expert agreement and gold standard development
Five Successive Levels of Agreement Agreement Criteria(on)
Woman-Level Recall
Breast-Level Recall and laterality
Lesion-Level Recall, laterality, location
Finding-Level Recall, laterality, location, finding type
Complete Agreement Recall, laterality, location, finding type, difficulty
Two Methods for Establishing Gold Standard Interpretation
- Require all three experts to agree
- Majority opinion, requiring only two of three experts to agree
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Table 2





 40–44 47 15
 45–49 57 18.2
 50–54 64 20.4
 55–59 66 21
 60–64 50 15.9
 65–69 30 9.6
Current HT use
 No 192 63.8
 Yes 109 36.2
 (Missing)‡ 13 (4.1)
Postmenopausal
 No 101 32.6
 Yes 209 67.4
 (Missing) ‡ 4 (1.3)
Breast density†
 BI-RADS 1 11 4.4
 BI-RADS 2 93 34.3
 BI-RADS 3 140 50.1
 BI-RADS 4 28 10.2
 (Missing) ‡ 42 (13.4)
Cancer w/in a year of screen
 No 171 54.5
 Yes 143 45.5
*
Cancer diagnosed within 12 months of screening mammogram
†
Breast density from clinical assessment
‡
Missing values not included in column percentages
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Table 3





 Ductal carcinoma in situ (DCIS) 27 18.9
 All Invasive 116 81.1
Cancer size† (mm)
 ≤ 5 13 11.9
 6–10 24 22.0
 11–15 25 22.9
 16–20 22 20.2
 > 20 25 22.9
 Unknown‡ 7 (6.0)
Axillary lymph node status†
 Negative 79 71.2
 Positive 32 28.8
 Unknown‡ 5 (4.3)
Grade†
 1: Well differentiated 20 20.2
 2: Moderately differentiated 46 46.5
 3: Poorly differentiated 32 32.3
 4: Undifferentiated 1 1.0
 Unknown‡ 17 (14.7)
ER/PR status†
 ER+/PR+ 60 71.4
 ER+/PR− 11 13.1
 ER−/PR+ 0 0.0
 ER−/PR− 13 15.5




Unknown values not included in column percentages
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Table 5
Agreement among all 3 experts.
All 3 agree Majority opinion: Require any 2 of 3 agree
No Cancer Cancer No Cancer Cancer
N=171 N=143 N=171 N=143
Recall N (%) N (%) N (%) N (%)
 Agree on no-recall 64 (37.4) 13 (9.1) 135 (78.9) 30 (21.0)
 Disagree on recall 96 (56.1) 55 (38.5) N/A N/A
 Agree to recall 11 (6.4) 75 (52.4) 36 (21.1) 113 (79.0)
Overall agreement
 Woman-level 75 (43.9) 88 (61.5) 171 (100.0) 143 (100.0)
 Breast-level 75 (43.9) 81 (56.6) 166 (97.1) 139 (97.2)
 Lesion-level 72 (42.1) 79 (55.2) 157 (91.8) 136 (95.1)
 Finding-level 70 (40.9) 58 (40.6) 151 (88.3) 126 (88.1)
 Complete 66 (38.6) 30 (21.0) 147 (86.0) 105 (73.4)
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Table 6
Agreement in finding type when experts recall the same lesion
Findings†
Number of experts who recalled the lesion
3 experts 2 of 3 experts
N %* N %*
All agree 51 69 38 70
 all C 21 41 13 34
 all M 19 37 10 26
 all AD 7 14 4 11
 all AS 4 8 11 29
Disagree 23 31 16 30
 C, M 1 4 2 13
 C, AD 0 0 4 25
 C, AS 3 13 0 0
 M, AD 1 4 2 13
 M, AS 16 70 6 38
 AS, AD 2 9 2 13
Total 74 100 54 100
†
C=Calcification; M=Mass; AD=Architectural distortion; AS=Asymmetry.
*
Percentages shown combination of finding types given by the experts, separately by whether or not there was agreement.
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